A study demonstrated that MSC intervention prevented DN progression via the LXA4-ALX/FPR2 axis, which inhibited glomerulosclerosis and pro-inflammatory cytokines, eventually contributing to kidney homeostasis [154]. The gene discussed is FPR2; the disease is liver dysplastic nodule.